Heart Failure Journal Issues Research Articles in October 2020 Edition
September 30, 2020
September 30, 2020
WASHINGTON, Sept. 30 -- Heart Failure, a peer-reviewed journal from the American College of Cardiology, published research articles on the following topics in its October 2020 edition:
FOCUS ISSUE: ANGIOTENSIN-NEPRILYSIN INHIBITION: NOVEL INSIGHTS:
* Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial
* Sacubitril/Valsartan: Neprilysin Inhibition 5 Years After PARADIGM-HF
* Eff . . .
FOCUS ISSUE: ANGIOTENSIN-NEPRILYSIN INHIBITION: NOVEL INSIGHTS:
* Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial
* Sacubitril/Valsartan: Neprilysin Inhibition 5 Years After PARADIGM-HF
* Eff . . .
